Jacob Abarca

Reliability evaluation of the adapted National Coordinating Council Medication Error Reporting and Prevention (NCC MERP) index

Rita Snyder, Jacob Abarca, Jane L. Meza et al. · Pharmacoepidemiology and Drug Safety · 2007 · 215 citations

Concordance of Severity Ratings Provided in Four Drug Interaction Compendia

Jacob Abarca, Daniel C. Malone, Edward P. Armstrong et al. · Journal of the American Pharmacists Association · 2004 · 207 citations

Drug Safety, Drug Interactions, Substance Abuse +11

Identification of Serious Drug–Drug Interactions: Results of the Partnership to Prevent Drug–Drug Interactions

Daniel C. Malone, Edward P. Armstrong, Jacob Abarca et al. · Journal of the American Pharmacists Association · 2004 · 189 citations

Drug Interactions, Substance Abuse, Prevent Drug–drug Interactions +8

Pharmacist Workload and Pharmacy Characteristics Associated With the Dispensing of Potentially Clinically Important Drug-Drug Interactions

Daniel C. Malone, Jacob Abarca, Grant H. Skrepnek et al. · Medical Care · 2007 · 126 citations

Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation

Gboyega Adeboyeje, Gosia Sylwestrzak, John J. Barron et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 115 citations · Full text

Bleeding Risk, Pharmacotherapy, Logistic Analysis +22